Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Diclehan Öktüren Oral"'
Publikováno v:
Dicle Medical Journal, Vol 31, Iss 3, Pp 1-6 (2004)
Beginning with the therapeutic dose and increasing three differentdoses and three different periods of time Bleomycin (Bleomycin 0.3 μg/ml, 3μg/ml and 30 μg/ml, 6,24, 48 hours) were added to blood which was beingcultured on 5 samples who were expo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::8a1168af40a930599bb2d68d291e4bd0
http://4181.indexcopernicus.com/fulltxt.php?ICID=887940
http://4181.indexcopernicus.com/fulltxt.php?ICID=887940
Publikováno v:
Dicle Medical Journal, Vol 31, Iss 2, Pp 4-8 (2004)
Beginning with the therapeutic dose and increasing three differentdoses and three different periods of time Bleomycin (Bleomycin 0.3 μg/ml, 3μg/ml and 30 μg/ml, 6, 24, 48 hours) were added to blood which was beingcultured on 5 samples who were exp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::378a011ebc9901837393d4859ff8ad56
http://4181.indexcopernicus.com/fulltxt.php?ICID=887895
http://4181.indexcopernicus.com/fulltxt.php?ICID=887895
Autor:
Diclehan Öktüren Oral, Hilmi İsi
Publikováno v:
Dicle Medical Journal, Vol 31, Iss 3, Pp 50-56 (2004)
Bleomycin in doses 0.3, 3 and 30 μg/ml was used with periods 6, 24 and48 hours on 5 male samples who were smokers, in in-vitro conditions andunder control so totally 3000 metaphases were evaluated.Structural chromosome aberrations were influenced by
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doajarticles::ded6f0fcbec55f320224138b44c528ac
http://4181.indexcopernicus.com/fulltxt.php?ICID=887948
http://4181.indexcopernicus.com/fulltxt.php?ICID=887948